OncoMyx Therapeutics completes $25M Series A financing - Read ArticleOncoMyx Therapeutics completes $25M Series A financingJune 5, 2019
Private equity firm buys Phoenix-based Axolotl Biologix - Read ArticlePrivate equity firm buys Phoenix-based Axolotl BiologixMay 8, 2019
$10 million gift will build first-of-its-kind X-ray facility at ASU - Read Article$10 million gift will build first-of-its-kind X-ray facility at ASUApril 18, 2019
TGen and HonorHealth contribute to Nature study - Read ArticleTGen and HonorHealth contribute to Nature studyApril 17, 2019
TGen finds gene associated with most common liver cancer - Read ArticleTGen finds gene associated with most common liver cancerApril 7, 2019
UA immunobiologist will explore copper’s potential as antibiotic - Read ArticleUA immunobiologist will explore copper’s potential as antibioticMarch 31, 2019
$6.1M in grants pave way for TGen-led studies of deadly lung diseases - Read Article$6.1M in grants pave way for TGen-led studies of deadly lung diseasesMarch 27, 2019
ASU receives $50M gift in support of dementia research, education - Read ArticleASU receives $50M gift in support of dementia research, educationMarch 25, 2019
TGen develops program that lights up cancer-causing mutations - Read ArticleTGen develops program that lights up cancer-causing mutationsMarch 20, 2019
TGen plays key role in pancreatic cancer breakthrough - Read ArticleTGen plays key role in pancreatic cancer breakthroughMarch 4, 2019
Scottsdale-based PathogenDx expands staff and footprint - Read ArticleScottsdale-based PathogenDx expands staff and footprintFebruary 25, 2019
Flinn Foundation names new leaders Bioscience Roadmap committee - Read ArticleFlinn Foundation names new leaders Bioscience Roadmap committeeFebruary 13, 2019